Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.7 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |